 Axel Schonthal, PhD
|
| Title(s) | Associate Professor of Molecular Microbiology & Immunology |
|---|
| Address | HMR 405A 2011 Zonal Avenue
Health Sciences Campus
Los Angeles CA 90089
|
|---|
| Phone | +1 323 442 1730 |
|---|
| vCard | Download vCard |
|---|
|
|
| Title(s) | Associate Dean for Biomedical Master's Programs |
|---|
|
|---|
|
 Biography | University of Karlsruhe, Germany | PhD | | Molecular Biology | | UC San Diego, San Diego, CA | Postdoc | | Cancer Biology |
Overview The Schonthal lab performs preclinical cancer research and pursues anticancer drug development. The main focus is on brain malignancies, which include primary brain cancers (such as glioblastoma) and secondary brain cancers (such as melanoma or breast cancer that has spread to the brain). The work is done in collaboration with Dr. Thomas Chen, Director of the USC Brain Tumor Group, and Dr. Florence Hofman from the Department of Pathology. This joint approach supports interdisciplinary efforts that translate laboratory findings to patient applications.
Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
A perillyl alcohol-conjugated analog of 3-bromopyruvate without cellular uptake dependency on monocarboxylate transporter 1 and with activity in 3-BP-resistant tumor cells. Cancer Lett. 2017 08 01; 400:161-174.
Chen TC, Yu J, Nouri Nigjeh E, Wang W, Myint PT, Zandi E, Hofman FM, Schönthal AH. PMID: 28450161.
View in: PubMed Mentions: 1 Fields: Translation: HumansCells
-
Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases. Int J Mol Sci. 2016 Sep 02; 17(9).
Chen TC, Da Fonseca CO, Schönthal AH. PMID: 27598140.
View in: PubMed Mentions: 3 Fields: Translation: HumansAnimals
-
Chemotherapeutic effect of a novel temozolomide analog on nasopharyngeal carcinoma in vitro and in vivo. J Biomed Sci. 2015 Aug 19; 22:71.
Chen TC, Cho HY, Wang W, Wetzel SJ, Singh A, Nguyen J, Hofman FM, Schönthal AH. PMID: 26282951.
View in: PubMed Mentions: 6 Fields: Translation: HumansAnimals
-
Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy. Am J Cancer Res. 2015; 5(5):1580-93.
Chen TC, Fonseca CO, Schönthal AH. PMID: 26175929.
View in: PubMed Mentions:
-
A novel temozolomide analog, NEO212, with enhanced activity against MGMT-positive melanoma in vitro and in vivo. Cancer Lett. 2015 Mar 28; 358(2):144-151.
Chen TC, Cho HY, Wang W, Nguyen J, Jhaveri N, Rosenstein-Sisson R, Hofman FM, Schönthal AH. PMID: 25524552.
View in: PubMed Mentions: 4 Fields: Translation: HumansAnimalsCells
-
A novel temozolomide-perillyl alcohol conjugate exhibits superior activity against breast cancer cells in vitro and intracranial triple-negative tumor growth in vivo. Mol Cancer Ther. 2014 May; 13(5):1181-93.
Chen TC, Cho HY, Wang W, Barath M, Sharma N, Hofman FM, Schönthal AH. PMID: 24623736.
View in: PubMed Mentions: 11 Fields: Translation: HumansAnimalsCells
-
Pharmacological targeting of endoplasmic reticulum stress signaling in cancer. Biochem Pharmacol. 2013 Mar 01; 85(5):653-666.
Schönthal AH. PMID: 23000916.
View in: PubMed Mentions: 66 Fields: Translation: HumansCells
-
Adverse effects of concentrated green tea extracts. Mol Nutr Food Res. 2011 Jun; 55(6):874-85.
Schönthal AH. PMID: 21538851.
View in: PubMed Mentions: 13 Fields: Translation: HumansAnimals
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
| Year | Publications |
|---|
| 2011 | 1 | | 2012 | 1 | | 2014 | 2 | | 2015 | 2 | | 2016 | 1 | | 2017 | 1 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
|
Derived automatically from this person's publications.
_
People in Profiles who have published with this person.
_
People who share similar concepts with this person.
_
Search Department
_
|